Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$3.06
+9.46%
Mkt Cap $490.80M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+434.5%
Consensus $16.33 vs current $3.06
NASDAQ·Healthcare·Biotechnology
$3.06
+9.46%
Mkt Cap $490.80M
Buy
3
Hold
1
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+434.5%
Consensus $16.33 vs current $3.06